Literature DB >> 28980201

Sinonasal Secretory Carcinoma of Salivary Gland with High Grade Transformation: A Case Report of this Under-Recognized Diagnostic Entity with Prognostic and Therapeutic Implications.

Bin Xu1, Ruth Aryeequaye1, Lu Wang1, Nora Katabi2.   

Abstract

Secretory carcinoma (SC) is a recently described salivary gland carcinoma with characteristic ETV6-NTRK3 fusion. In this case report, we described a SC of the maxillary sinus that underwent high grade transformation in a 61-year-old patient. The diagnosis was confirmed by the presence of ETV6 translocation. Within the sinonasal tract, SC is an important differential diagnosis especially of sinonasal adenocarcinoma, non-intestinal type (non-ITAC), as these two entities bears histologic and immunophenotypic similarity. Distinction between these two tumors can be challenging based on the morphology alone and may require additional immunohistochemical and molecular studies. It is important to recognize that SC can occur in the sinonasal tract as correctly diagnosing SC may be prognostic relevant and may provide new targeted therapeutic avenues for these patients.

Entities:  

Keywords:  ETV6-NTRK3 fusion; High grade transformation; Secretory carcinoma; Sinonasal non-intestinal type adenocarcinoma

Mesh:

Substances:

Year:  2017        PMID: 28980201      PMCID: PMC5953877          DOI: 10.1007/s12105-017-0855-5

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  28 in total

1.  Sinonasal adenocarcinoma: a 16-year experience at a single institution.

Authors:  Mihir K Bhayani; Turker Yilmaz; Alex Sweeney; Gabriel Calzada; Dianna B Roberts; Nicholas B Levine; Franco DeMonte; Ehab Y Hanna; Michael E Kupferman
Journal:  Head Neck       Date:  2014-01-29       Impact factor: 3.147

2.  Low-grade nonintestinal sinonasal adenocarcinoma: a diagnosis of exclusion.

Authors:  Feriyl Bhaijee; Jeffrey Carron; Diana Bell
Journal:  Ann Diagn Pathol       Date:  2011-03-10       Impact factor: 2.090

3.  Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.

Authors:  Andre Pinto; Vania Nosé; Claudia Rojas; Yao-Shan Fan; Carmen Gomez-Fernandez
Journal:  Mod Pathol       Date:  2013-06-28       Impact factor: 7.842

4.  Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.

Authors:  Ashton Connor; Bayardo Perez-Ordoñez; Mary Shago; Alena Skálová; Ilan Weinreb
Journal:  Am J Surg Pathol       Date:  2012-01       Impact factor: 6.394

5.  Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib.

Authors:  Nicole A Cipriani; Elizabeth A Blair; Joshua Finkle; Jennifer L Kraninger; Christopher M Straus; Victoria M Villaflor; Daniel Thomas Ginat
Journal:  Int J Surg Pathol       Date:  2017-05-12       Impact factor: 1.271

Review 6.  Mammary analogue secretory carcinoma of salivary gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity.

Authors:  Alena Skalova
Journal:  Head Neck Pathol       Date:  2013-07-03

7.  Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.

Authors:  Ilan Weinreb; Salvatore Piscuoglio; Luciano G Martelotto; Daryl Waggott; Charlotte K Y Ng; Bayardo Perez-Ordonez; Nicholas J Harding; Javier Alfaro; Kenneth C Chu; Agnes Viale; Nicola Fusco; Arnaud da Cruz Paula; Caterina Marchio; Rita A Sakr; Raymond Lim; Lester D R Thompson; Simion I Chiosea; Raja R Seethala; Alena Skalova; Edward B Stelow; Isabel Fonseca; Adel Assaad; Christine How; Jianxin Wang; Richard de Borja; Michelle Chan-Seng-Yue; Christopher J Howlett; Anthony C Nichols; Y Hannah Wen; Nora Katabi; Nicholas Buchner; Laura Mullen; Thomas Kislinger; Bradly G Wouters; Fei-Fei Liu; Larry Norton; John D McPherson; Brian P Rubin; Blaise A Clarke; Britta Weigelt; Paul C Boutros; Jorge S Reis-Filho
Journal:  Nat Genet       Date:  2014-09-21       Impact factor: 38.330

Review 8.  Entrectinib: a potent new TRK, ROS1, and ALK inhibitor.

Authors:  Christian Rolfo; Rossana Ruiz; Elisa Giovannetti; Ignacio Gil-Bazo; Antonio Russo; Francesco Passiglia; Marco Giallombardo; Marc Peeters; Luis Raez
Journal:  Expert Opin Investig Drugs       Date:  2015-10-12       Impact factor: 6.206

9.  Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.

Authors:  Alena Skálová; Tomas Vanecek; Roderick H W Simpson; Jan Laco; Hanna Majewska; Martina Baneckova; Petr Steiner; Michal Michal
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

10.  What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).

Authors:  A Drilon; G Li; S Dogan; M Gounder; R Shen; M Arcila; L Wang; D M Hyman; J Hechtman; G Wei; N R Cam; J Christiansen; D Luo; E C Maneval; T Bauer; M Patel; S V Liu; S H I Ou; A Farago; A Shaw; R F Shoemaker; J Lim; Z Hornby; P Multani; M Ladanyi; M Berger; N Katabi; R Ghossein; A L Ho
Journal:  Ann Oncol       Date:  2016-02-15       Impact factor: 32.976

View more
  4 in total

1.  (Mammary Analogue) Secretory Carcinoma of the Nasal Cavity: Report of a Rare Case with p63 and DOG1 Expression and Uncommon Exon 4-Exon 14 ETV6-NTRK3 Fusion Diagnosed with Next Generation Sequencing.

Authors:  Bingcheng Wu; Thomas Kwok Seng Loh; Tomas Vanecek; Michal Michal; Fredrik Petersson
Journal:  Head Neck Pathol       Date:  2019-07-04

2.  Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors.

Authors:  Bin Xu; Kartik Viswanathan; Kavita Umrau; Thair A D Al-Ameri; Snjezana Dogan; Kelly Magliocca; Ronald A Ghossein; Nicole A Cipriani; Nora Katabi
Journal:  Histopathology       Date:  2022-09-05       Impact factor: 7.778

3.  Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland.

Authors:  Yuichiro Hamamoto; Hiroshi Harada; Masaharu Kohara; Keiichiro Honma; Shin-Ichi Nakatsuka; Eiichi Morii
Journal:  Med Mol Morphol       Date:  2020-06-01       Impact factor: 2.070

4.  Primary and Secondary/ Metastatic Salivary Duct Carcinoma Presenting within the Sinonasal Tract.

Authors:  Abbas Agaimy; Sarina K Mueller; Justin A Bishop; Simion I Chiosea
Journal:  Head Neck Pathol       Date:  2021-01-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.